A Global Asset Management Seoul Korea Magazine
A man holding up a smartphone with the Uber transport app visible on screen, while taxis queue in the background, on June 4, 2019. (Photo by Olly Curtis/Future via Getty Images) Olly Curtis | Future | Getty Images Uber won its legal fight to continue operating in London on Monday, as a judge overturned a ban on the ride-hailing app by the city's transport regulator. Last year, TfL stripped Uber of its license for a second time — it first declined to renew Uber's London license in 2017 — citing a "pattern of failures" that had put passengers at risk. The watchdog said a glitch in Uber's systems allowed unauthorized drivers to upload their photos to other driver accounts and fraudulently pick up passengers in at least 14,000 journeys. Handing down his decision at the Westminster Magistrates' Court on Monday, Judge Tan Ikram said he had "sufficient confidence" Uber "no longer poses a risk to public safety." "Despite their historical failings, I find (Uber), now, to be a fit and proper person to hold a London PHV (private hire vehicle) operator's licence," Ikram said in his judgement. Uber shares climbed 6% in premarket trading
THE HAGUE (REUTERS) - One of four suspects being tried in absentia for the 2014 downing of Malaysia Airlines Flight 17 has denied any involvement with firing or supplying the missile used in its destruction, a lawyer said in court on Monday (Sept 28). MH17 was flying from Amsterdam to Kuala Lumpur when it was shot down by a missile fired from territory held by pro-Russian rebels during fighting in eastern Ukraine. All 298 people aboard were killed. After an international investigation lasting nearly six years, four defendants went on trial in absentia in March, of whom only Oleg Pulatov has instructed a lawyer to defend him. "He did not contribute and he was not involved. What's more, he did not and does not have any knowledge of how and why MH17 was downed," his lawyer Sabine ten Doesschate said at the Hague District Court.
Global Celiac Disease (CD) Market Insights, Epidemiology and Market Forecasts, 2017-2019 & 2020-2030
Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Celiac Disease (CD) - Market Insights, Epidemiology and Market Forecast- 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.The Celiac Disease (CD) - Market Insights, Epidemiology and Market Forecast- 2030' report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.The Celiac Disease (CD) market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Celiac Disease (CD) market size from 2017 to 2030. The report also covers current Celiac Disease (CD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.Celiac Disease (CD) EpidemiologyThe disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Population of Celiac Disease (CD), Total Diagnosed Prevalent Population of Celiac Disease (CD), Gender-specific Prevalent Population of Celiac Disease (CD), Type-specific Prevalent Population of Celiac Disease (CD) and Age-specific Distribution of Celiac Disease (CD) in the 7MM market covering the United